There is a scene in the great movie, “Independence Day” (1996; the sequel never happened) where Randy Quaid says, “I been sayin’ it. Ain’t I been sayin’ it?” He had been trying to make people aware of aliens for 10 dang years. I’ve got him beat; I have been encouraging men to be their […]
Does everyone with prostate cancer need genetic testing? No. Many men are diagnosed with low-risk or intermediate-risk localized cancer, cancer that may not need to be treated immediately or maybe even ever. But as we discussed in Part 1 of my discussion with Oregon Health Sciences University medical oncologist Alexandra Sokolova, M.D., some men […]
Does Cancer Run in Your Family? If you have high-risk or metastatic prostate cancer, you may have been born with a faulty gene, and you should strongly consider “germline” genetic testing, testing of the genes you were born with. In my work for the Prostate Cancer Foundation, I recently interviewed an expert on germline genetic […]
Lessons from a Prostate Cancer Survivor Ric Siler fought prostate cancer twice, both times with doctors who were going for a cure. Today, five years out, he’s cancer-free and sharing his message of hope with other men and their families. You’re minding your own business and happily living your life, as most of us […]
New research opens up a whole new avenue for treating advanced prostate cancer. One of the best things about working as a writer for the Prostate Cancer Foundation (PCF) is that I have gotten to interview scientists doing some of the most promising research on prostate cancer, a disease that I can’t seem to get […]
Heartburn, also called GERD (gastro-esophageal reflux disease), is miserable. To review what causes it, see this post. Now, let’s talk about how to make it better. I know this subject better than I’d like to, and if you suffer from heartburn, I feel your pain: I, too, am a reluctant member of the GERD herd. So. […]
Roadblocks to Combination Therapy, and Paving the Way for Success As we discussed in Part 1, the year 2015 was a milestone in treatment of early metastasis (metastatic hormone-sensitive prostate cancer, or mHSPC). For the first time, the CHAARTED study showed that men with mHSPC who began ADT (androgen deprivation therapy, which shuts down […]